Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

Author(s): Xiaohui Wang, Xiaolei Li, Xiaoyu Fu, Miaomiao Bai, Xiang Li, Qian Mei, Jing Nie, Zhiqiang Wu, Weidong Han

Journal Name: Current Protein & Peptide Science

Volume 16 , Issue 4 , 2015

Become EABM
Become Reviewer


Tumor recurrence followed by chemoresistance is a major cause of the poor survival rates for ovarian cancer. Despite advances in ovarian cancer chemotherapies and increased knowledge of the characteristics of ovarian cancer, chemoresistance is still an enormous clinical challenge. Current research suggests that ovarian cancer stem cells (OCSCs) might be involved in the occurrence of chemoresistance in ovarian cancer. In this review, we focus on the relationship of ovarian cancer stem cells with drug-resistant ovarian cancer phenotypes. We also discuss the current knowledge regarding ovarian cancer stem cellbased therapeutic strategies as attempts to overcome chemoresistance, the largest obstacle for successful treatment. Finally, we discuss methods for improving the treatment outcomes of ovarian cancer patients with chemoresistance.

Keywords: OCSCs, ovarian cancer, chemoresistance, therapeutic target.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [270 - 278]
Pages: 9
DOI: 10.2174/138920371604150429151457
Price: $65

Article Metrics

PDF: 62
PRC: 1